Shenzhen Lifotronic Technology Co., Ltd. (SHA:688389)
China · Delayed Price · Currency is CNY 14.12
-0.08 (-0.56%)
Sep 15, 2025, 2:45 PM CST
SHA:688389 Revenue
Shenzhen Lifotronic Technology had revenue of 291.90M CNY in the quarter ending June 30, 2025, with 2.71% growth. This brings the company's revenue in the last twelve months to 1.06B, down -9.54% year-over-year. In the year 2024, Shenzhen Lifotronic Technology had annual revenue of 1.15B with 0.20% growth.
Revenue (ttm)
1.06B
Revenue Growth
-9.54%
P/S Ratio
5.68
Revenue / Employee
637.70K
Employees
1,670
Market Cap
6.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.15B | 2.32M | 0.20% |
| Dec 31, 2023 | 1.15B | 162.67M | 16.55% |
| Dec 31, 2022 | 983.04M | 204.94M | 26.34% |
| Dec 31, 2021 | 778.11M | 224.28M | 40.50% |
| Dec 31, 2020 | 553.82M | 131.18M | 31.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |